Centre Hospitalier Universitaire De Nantes
Centre Hospitalier Universitaire De Nantes is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
MInimal residual Disease Adapted Strategy / IFM 2020-02: frontline therapy for patients eligible for autologous stem cell transplantation less than 66 years; a prospective study from the French cooperative group IFM
Sponsor Intergroupe Francophone Du Myelome
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A multicenter phase 1/2 dose-finding and dose expansion study of OSE-279, a PD-1 blocking monoclonal antibody, in subjects with advanced solid tumors or lymphomas
Sponsor OSE Immunotherapeutics
- Start (EU)
- Latest update
- Estimated end
- Not reported
Safety and Efficacy of a Unilateral Subretinal Administration of HORA PDE6B in Patients with Retinitis Pigmentosa Harbouring Mutations in the PDE6B Gene Leading to a Defect in PDE6ß Expression
Sponsor eyeDNA Therapeutics
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Centre Hospitalier Universitaire De Nantes?
The 2026-10-09 snapshot links Centre Hospitalier Universitaire De Nantes to 3 distinct CTIS trials. Recorded services include Laboratory services, Medicinal product management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Centre Hospitalier Universitaire De Nantes?
The most frequently recorded therapeutic areas are Haematological Malignancies, Solid Tumor Oncology. Recorded phases include Phase 1, Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Centre Hospitalier Universitaire De Nantes conducted?
The linked trials record locations in 3 countries, including France, Belgium, Spain. These are trial locations, not confirmed office locations or countries where Centre Hospitalier Universitaire De Nantes delivered services.
What can this page tell me about Centre Hospitalier Universitaire De Nantes's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Centre Hospitalier Universitaire De Nantes. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Centre Hospitalier Universitaire De Nantes